| | | | | |
AGIO Agios Pharmaceuticals, Inc. | $29,4000 | +0,00 % | $1,74B | $1,00M | |
SGRY Surgery Partners, Inc. Common Stock | $13,3600 | +0,00 % | $1,74B | $967,56K | |
GAB The Gabelli Equity Trust Inc. | $5,6100 | +0,00 % | $1,74B | $1,01M | |
HURN Huron Consulting Group Inc. | $107,26 | -0,12 % | $1,74B | $128,69K | |
ENVX Enovix Corporation Common Stock | $7,9800 | +0,00 % | $1,74B | $8,79M | |
PAYO Payoneer Global Inc. Common Stock | $5,2000 | +0,00 % | $1,74B | $3,19M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $14,9000 | +0,00 % | $1,73B | $255,79K | |
STGW Stagwell Inc. Class A Common Stock | $7,0200 | +0,14 % | $1,73B | $1,73M | |
CASH Pathward Financial, Inc. Common Stock | $82,1000 | -0,17 % | $1,73B | $77,66K | |
SNDX Syndax Pharmaceuticals, Inc. | $19,5900 | +0,00 % | $1,73B | $584,91K | |
STRA Strategic Education, Inc. Common Stock | $76,8100 | +0,08 % | $1,73B | $159,48K | |
CAPR Capricor Therapeutics Inc | $29,9500 | -0,03 % | $1,73B | $564,63K | |
AAPG Ascentage Pharma Group International American Depository Shares | $20,2100 | +1,00 % | $1,73B | $15,54K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | $9,3050 | -0,05 % | $1,73B | $21,77M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | $25,0000 | +0,00 % | $1,73B | $176,82K | |
